Franklin Genomic Advancements ETF (HELX) Investment Research Dashboard
About Franklin Genomic Advancements ETF (HELX) stock analysis
Get live HELX stock price $38.70, comprehensive Franklin Genomic Advancements ETF stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HELX stock data and investment insights.
Loading chart data...
Franklin Genomic Advancements ETF (HELX) Overview
Franklin Genomic Advancements ETF (HELX) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, HELX trades at $38.70 with a market capitalization of 19.27M . Over the past 52 weeks, HELX has traded between $27.54 and $41.30 , with the current price positioned at approximately 81% of this range . The ...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 19.27M
- Current price: $38.70
- 52-week range: $27.54 - $41.30
- P/E ratio: 32.65
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassin...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- One Franklin Parkway
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 32.6)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Franklin Genomic Advancements ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Franklin Genomic Advancements ETF
- ⚠Investors should consider how Franklin Genomic Advancements ETF fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 32.6) requires strong growth to justify
Market Cap
19.27M
P/E Ratio (TTM)
32.65
Beta
0.98
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HELX with peer companies:
- Price
- $41.08-1.34% (1D)
- Market cap
- 20.80M
- Price
- $28.16-0.62% (1D)
- Market cap
- 25.38M
- Price
- $36.12+0.46% (1D)
- Market cap
- 15.57M
- Price
- $21.28-1.82% (1D)
- Market cap
- 18.32M
- Price
- $35.86+1.49% (1D)
- Market cap
- 19.27M
- Price
- $14.92-0.30% (1D)
- Market cap
- 15.83M
- Price
- $21.28-0.59% (1D)
- Market cap
- 17.47M
- Price
- $24.90-1.97% (1D)
- Market cap
- 17.51M
- Price
- $43.86+0.18% (1D)
- Market cap
- 11.43M
- Price
- $40.80-0.48% (1D)
- Market cap
- 16.59M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
98/100 ⭐⭐⭐⭐⭐
- Overall
- -0.0%
- NYSE
- -0.4%
- NASDAQ
- +0.3%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | -0.0% | +3.3% | +3.8% | 19.1 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | +1.2% | +2.6% | 22.1 | 81/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +0.9% | +2.8% | +2.4% | 29.9 | 72/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.5% | +2.2% | +2.3% | 24.0 | 71/100⭐⭐⭐⭐⭐ |
| Real Estate | -1.3% | -1.0% | -2.4% | 28.8 | 50/100⭐⭐⭐ |
| Energy | -0.1% | -3.8% | -3.2% | 19.5 | 48/100⭐⭐⭐ |
| Basic Materials | -2.0% | -1.3% | -2.7% | 24.7 | 44/100⭐⭐⭐ |
| Consumer Cyclical | +0.1% | -0.7% | -6.7% | 42.2 | 34/100⭐⭐ |
| Industrials | -1.4% | -0.3% | -13.0% | 29.2 | 22/100⭐ |
| Utilities | -2.1% | -4.1% | -7.0% | 26.1 | 22/100⭐ |
| Technology | -1.4% | -4.2% | -11.4% | 40.3 | 9/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.